Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease

Frontiers in Oncology(2022)10.3389/fonc.2022.849993Source: DataRank Database

Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.55)OA: goldTopics (53)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Akifumi Hagiwara ORCID,Jingwen Yao ORCID,Catalina Raymond ORCID,Christian Ong,Rojin Bakhti

Live enrichment

PubMed:35371980 PMC:PMC8964348 OpenAlex:https://openalex.org/W4220983528

NCI NIH HHS

Grant: P50 CA211015

National Institutes of Health

Grant: 5P50CA211015-02

UCLA SPORE in Brain Cancer

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Cancer Institute

National Institutes of Health

American Cancer Society

FWCI

0.55

Citation Percentile

0.6%

Influential Citations

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fonc.2022.849993/pdf

GOLDhttps://www.frontiersin.org/articles/10.3389/fonc.2022.849993/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.849993/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.849993/full

journalhttps://doi.org/10.3389/fonc.2022.849993

Fields of Study

Glioma Diagnosis and TreatmentBrain Metastases and TreatmentMRI in cancer diagnosisMedicine03 medical and health sciences0302 clinical medicine

Keywords

GlioblastomaOncologyInternal medicineProgression-free survivalMedicineCerebral blood volumeCancer researchTemozolomideWild typeChemoradiotherapyOverall survivalBiologyGeneCerebral blood flowGeneticsChemoradiationMgmt MethylationRcbvDynamic Susceptibility Contrast Perfusion MriOncology and Carcinogenesis610Health Disparities (rcdc)Clinical sciencesRare Diseases (rcdc)Clinical Research (rcdc)Rare DiseasesClinical ResearchBrain Disorders (rcdc)3211 Oncology and carcinogenesis (for-2020)Minority Health32 Biomedical and Clinical Sciences (for-2020)Neurosciences (rcdc)RC254-282CancerCancer (rcdc)Brain Cancer (rcdc)Biomedical and Clinical SciencesNeurosciencesNeoplasms. Tumors. Oncology. Including cancer and carcinogens600Cancer (hrcs-hc)3202 Clinical sciences (for-2020)1112 Oncology and Carcinogenesis (for)Brain DisordersHealth DisparitiesBrain CancerMinority Health (rcdc)

Sustainable Development Goals

SDG 0: Good health and well-being